Skip to main content
. 2009 Feb 23;11(3):356–361. doi: 10.1038/aja.2008.32

Table 2. IIEF scores of the TMGE-treated group and the placebo-treated group.

Group (n) Pre-medication (Mean ± SD) Post-medication (Mean ± SD) P-value
Total IIEF
  TMGE (65) 29.78 ± 13.14 39.86 ± 15.29 < 0.00
  Placebo (21) 29.71 ± 10.58 33.33 ± 10.17 0.242
EF domain
  TMGE (65) 11.89 ± 5.89 16.37 ± 7.08 < 0.00
  Placebo (21) 11.38 ± 4.78 13.05 ± 4.27 0.390
OF domain
  TMGE (65) 4.09 ± 2.49 5.32 ± 2.74 0.008*
  Placebo (21) 4.38 ± 1.47 5.00 ± 1.76 0.199
SD domain
  TMGE (65) 4.32 ± 1.59 5.58 ± 2.03 < 0.00
  Placebo (21) 4.33 ± 1.68 4.67 ± 1.62 0.411
IS domain
  TMGE (65) 5.12 ± 2.93 6.83 ± 2.95 0.001*
  Placebo (21) 5.57 ± 2.7 15.81 ± 2.54 0.859
OS domain
  TMGE (65) 4.29 ± 1.89 5.74 ± 1.93 < 0.00*
  Placebo (21) 4.05 ± 1.32 4.81 ± 1.44 0.106
IIEF-5
  TMGE (65) 11.02 ± 5.08 15.34 ± 6.13 < 0.00*
  Placebo (21) 11.95 ± 4.44 13.52 ± 4.46 0.471

Abbreviations: EF, erectile function; IIEF-5, the five-item version of the International Index of Erectile Function; IS, intercourse satisfaction; OF, orgasmic function; OS, overall satisfaction; SD, sexual desire; TMGE, tissue-cultured mountain ginseng extract.

*

Statistical significance was tested using the paired t-test and the Mann-Whitney test.